Literature DB >> 3360695

Treatment failure in Trichomonas vaginalis infections in females. I. Concentrations of metronidazole in plasma and vaginal content during normal and high dosage.

D H Robertson1, R Heyworth, C Harrison, W H Lumsden.   

Abstract

Concurrent estimation by high pressure liquid chromatography (HPLC) of the concentrations of metronidazole in plasma and vaginal content in 12 patients with infections due to Trichomonas vaginalis who did not respond to normal and high-dose treatment has shown that the two levels are closely related to each other and to the dose. Individual idiosyncrasies in absorption of drug from the gut lumen or in its transfer into the vaginal content are unlikely to be the cause of treatment failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360695     DOI: 10.1093/jac/21.3.373

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Effect of the antimicrobial peptide tritrpticin on the in vitro viability and growth of Trichomonas vaginalis.

Authors:  Veronica V Infante; Alma D Miranda-Olvera; Luis M De Leon-Rodriguez; Fernando Anaya-Velazquez; Mayra C Rodriguez; Eva E Avila
Journal:  Curr Microbiol       Date:  2010-07-17       Impact factor: 2.188

2.  An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test.

Authors:  K A Borchardt; Z Li; M Z Zhang; H Shing
Journal:  Genitourin Med       Date:  1996-04

Review 3.  Treatment failure in Trichomonas vaginalis vaginitis.

Authors:  W H Lumsden; D H Robertson; R Heyworth; C Harrison
Journal:  Genitourin Med       Date:  1988-08

4.  In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.

Authors:  E M Narcisi; W E Secor
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  Effect of recombinant prophenin 2 on the integrity and viability of Trichomonas vaginalis.

Authors:  J L Hernandez-Flores; M C Rodriguez; A Gastelum Arellanez; A Alvarez-Morales; E E Avila
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.